Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
The escalating global incidence of cancer has emphasised the urgency for innovative therapeutic strategies. Monoclonal antibodies (mAbs) have emerged as promising candidates for cancer treatment, driving the pursuit of tumour-targeted therapies. Rituximab (RTX) is one such mAb which has been of subs...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | Eng |
| Published: |
Department of Medicine
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|